A man receiving abiraterone for prostate cancer developed severe hypokalemia, which led to polymorphic ventricular tachycardia and cardiac arrest. It is important to consider iatrogenic causes in cases of arrhythmia.
SGLT2 inhibitors reduce the risk of incident gout and gout flares in patients with type 2 diabetes and offer cardiovascular benefits, compared with sulfonylureas.
New trial results show routine use of a microaxial flow pump reduces all-cause mortality risk among patients with STEMI complicated by cardiogenic shock.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.
A man receiving abiraterone for prostate cancer developed severe hypokalemia, which led to polymorphic ventricular tachycardia and cardiac arrest. It is important to consider iatrogenic causes in cases of arrhythmia.
How should you react to an acute MI immediately after a craniotomy for tumor resection? Management of such patients requires carefully balancing the competing risks of myocardial ischemia and postoperative bleeding.
The recommended protocol for treating ST-segment elevation myocardial infarction (STEMI), as outlined by the National Institute for Health and Care Excellence (NICE) guidelines [ 1 ], involves primary percutaneous coronary intervention (PCI), which …
Heart failure continues to be a significant global health concern, causing substantial morbidity and mortality. The limited ability of the adult heart to regenerate has posed challenges in finding effective treatments for cardiac pathologies.
Acute myocardial infarction is an important cardiovascular disease worldwide. Although the mortality rate of myocardial infarction (MI) has improved dramatically in recent years due to timely treatment, adverse remodeling of the left ventricle …
Heart failure and myocardial infarction, global health concerns, stem from limited cardiac regeneration post-injury. Myocardial infarction, typically caused by coronary artery blockage, leads to cardiac muscle cell damage, progressing to heart …
An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.
Cardiac disease is the leading cause of death in both urban and rural residents in China. High long-term mortality is mostly caused by HF and other MACE following AMI [ 1 ]. PCI and guideline-directed medical therapy can reduce the in-hospital …
Heart failure continues to be a significant global health concern, causing substantial morbidity and mortality. The limited ability of the adult heart to regenerate has posed challenges in finding effective treatments for cardiac pathologies.
The number of myocardial infarctions declined during the early COVID-19 pandemic but mechanisms behind these declines are poorly understood. COVID-19 infection is also associated with an increased risk of myocardial infarction which could lead to …
The management of patients with acute myocardial infarction (AMI) and large thrombus burden (LTB) remains challenging. Despite the advent of potent antithrombotic regimens, percutaneous coronary intervention (PCI) in AMI cases with LTB often …